Prime Health Services
- IV Therapy
- IV Hydration
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Las Vegas, NV
Las Vegas is the single most hangover-driven IV therapy market in the country, and the density of clinics reflects it. Mobile IV services dominate the Strip and Downtown, delivering drips directly to Wynn, Bellagio, Aria, and Fontainebleau hotel rooms, often within 45 minutes of a booking. Brick-and-mortar lounges concentrate in Summerlin, Henderson, and along Rainbow Boulevard. Nevada is a full-practice state for nurse practitioners, which shapes local workflows, though most drip services still operate on a physician medical director model with RNs administering. The desert's extreme dry heat drives steady hydration demand well beyond tourism, and the Las Vegas fight scene, EDC, and convention economy produce predictable spikes. Sunrise Health, Valley Health, and University Medical Center supply many of the city's IV medical directors. Mobile providers here have built the most sophisticated concierge logistics of any IV market in the US.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Nevada medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.